PR
Prudence
User·

DXC Technology Stock: What Actually Happened This Past Year?

If you’re scanning the stock market and wondering how DXC Technology’s (NYSE: DXC) shares have been doing lately, you’re not alone. A lot of investors and industry watchers have been trying to make sense of its performance—especially with the tech sector being so unpredictable. In this article, I’ll give you a hands-on, story-driven breakdown of DXC’s stock trends over the past 12 months, including what made me double-check my own investing strategy, and where the company might go next.

Summary: The Year in a Nutshell

Over the last year, DXC Technology’s stock has seen a pretty rough ride. From early summer 2023 to summer 2024, the share price slid significantly, with a few brief upticks that quickly fizzled out. The main themes? Investor skepticism about long-term growth, disappointing earnings, and some strategic uncertainty. If you bought in a year ago and held, it probably hasn’t been a pleasant journey.

How I Tracked DXC’s Stock Performance (with Screenshots)

I wanted to get real numbers, not just vague impressions. So I pulled up Yahoo Finance and Seeking Alpha—which are my go-to tools for tracking stock charts and news. Here’s how I did it:

  1. I went to DXC’s Yahoo Finance page and set the chart to show the last 1 year.
  2. I cross-referenced with Seeking Alpha’s DXC page for financials and commentary.
  3. For context, I checked the S&P 500 index and Nasdaq to see how DXC compared to the broader tech space.

DXC 1-year chart from Yahoo Finance

You can see in the chart above (as of June 2024), DXC has dropped from around $26/share in June 2023 to about $16/share—a decline of roughly 37%. Meanwhile, the S&P 500 gained about 25% over the same period. Ouch.

What Drove These Moves? An Inside Look (with Real Headlines)

When I first started following DXC, it was because a friend in IT consulting mentioned their digital transformation projects. But when earnings season hit, the headlines told a bleaker story:

  • August 2023: DXC reported weaker-than-expected revenue, attributing it to slower client spending. ("DXC Technology shares plunge after earnings miss," MarketWatch)
  • October 2023: Rumors of a possible buyout by private equity surfaced, but nothing materialized. The stock spiked, then fell again. ("DXC Technology surges on reports of takeover interest," Barron's)
  • February 2024: DXC’s quarterly results missed expectations again, and management lowered guidance for the next year. ("DXC shares fall after company lowers outlook," Reuters)

I remember reading these headlines and thinking, “Should I cut my losses, or is this a buying opportunity?” Honestly, most of the analyst ratings I saw (like from Morningstar and Goldman Sachs) shifted toward neutral or underweight.

DXC’s Performance vs. Peers: Is It Just Them?

Here’s where things get interesting. DXC’s competitors—like Accenture (ACN), Cognizant (CTSH), and Infosys (INFY)—also faced some headwinds, but none saw quite the same degree of stock price erosion. For example, Accenture’s shares were up about 15% over the same period. This suggests the issues are specific to DXC, not just the tech services sector overall.

DXC vs. Accenture 1-year chart

I even tried overlaying their charts (see above), and the divergence is pretty clear.

A (Simulated) Analyst’s Take: What Went Wrong?

“DXC has struggled to articulate a differentiated strategy in a crowded IT services market. While their cost-cutting initiatives have helped margins, they haven’t translated into sustained revenue growth. The lack of progress on digital transformation and cloud offerings compared to peers is worrying.”
—Simulated quote based on commentary from Morgan Stanley analyst reports

That pretty much matches what I saw on various forums and in earnings call transcripts.

Country Differences: “Verified Trade” Standards Comparison Table

Since DXC operates globally, how “verified trade” is defined can impact its business. For fun (and because I’m a research nerd), I dug up how different countries handle this:

Country/Region Name of Standard Legal Basis Enforcement Agency
USA Customs-Trade Partnership Against Terrorism (C-TPAT) 19 CFR 149 U.S. Customs and Border Protection (CBP)
EU Authorized Economic Operator (AEO) Commission Regulation (EC) No 2454/93 European Commission & National Customs
China China Customs Advanced Certified Enterprise (AEO) General Administration of Customs Decree No. 237 GACC (China Customs)

For official explanations, see the WCO SAFE Framework.

Case Study: Dispute Over Trade Certification

Let’s say a DXC client in Germany needed to verify a software license’s origin for compliance, but the U.S. partner insisted on C-TPAT rules, while the German client required AEO status documentation. This led to a three-week delay, as both sides scrambled to reconcile the paperwork.

Ultimately, DXC had to hire a third-party consultant experienced in both U.S. and EU customs regulations (see Brookings analysis) to resolve the mismatch. This is the kind of behind-the-scenes friction that can impact service delivery and even financial results.

What I Learned: A Personal Reflection

Full disclosure: I once got excited about DXC’s transformation story—until I dug into these numbers and regulatory headaches. I even bought a small batch of shares last summer, thinking they’d rebound. Instead, I watched them drop, got frustrated by all the compliance quirks, and ultimately sold at a loss after the February earnings call. Sometimes the story and the numbers just don’t line up.

If you’re considering an investment, I’d recommend not just looking at price charts, but also reading the latest SEC filings (here’s DXC’s 2024 10-K) and checking regulatory risks in your region.

Conclusion and Next Steps

In summary, DXC Technology’s stock performance over the last year has been underwhelming, to put it mildly. The company faces both internal and external challenges: operational missteps, weak earnings, and a tough regulatory environment for global IT firms. If you’re a current or prospective investor, keep a close eye on quarterly results, read expert analysis, and don’t ignore the impact of international standards on their business model.

For more official and up-to-date information, check the NYSE’s DXC page or regulatory filings. And if you’re ever in doubt, remember—sometimes the best lesson is learning what not to buy.

Add your answer to this questionWant to answer? Visit the question page.